Agree. MTX will have a far bigger market to BTM. Consider all the diabetic ulcers plus infected wounds, necrotising fasceiitis , pilonoidal sinus ops as well as trauma and arterial and venous ulcers. I was impressed with the number of hospitals using our product, nearly 550 and more added to day to get close to 600. EU is a bit of a laggard but should catch up with the US with time and the EU population is 700m
- Forums
- ASX - By Stock
- Ann: NovoSorb MTX First Sales and March 2023 $6m Revenue
Agree. MTX will have a far bigger market to BTM. Consider all...
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.42 |
Change
0.100(4.31%) |
Mkt cap ! $1.660B |
Open | High | Low | Value | Volume |
$2.39 | $2.45 | $2.38 | $2.220M | 920.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 68324 | $2.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.42 | 52576 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
68 | 69338 | 2.410 |
30 | 104571 | 2.400 |
17 | 49199 | 2.390 |
14 | 36905 | 2.380 |
8 | 59576 | 2.370 |
Price($) | Vol. | No. |
---|---|---|
2.420 | 57001 | 35 |
2.430 | 99717 | 19 |
2.440 | 129235 | 20 |
2.450 | 53885 | 18 |
2.460 | 26729 | 7 |
Last trade - 15.48pm 09/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |